Press Release

Category Added in a WPeMatico Campaign

Cision PR Newswire10 February 2026

100 Reasons to Celebrate: IXL Honors the Teachers Powering Today’s Classrooms

IXL’s Elite 100 recognizes educators who went the extra mile to help their students succeed SAN MATEO, Calif., Feb. 10,…
Read More »
Cision PR Newswire10 February 2026

ZINZINO AB (PUBL.): ZINZINO ANNOUNCES PERU AS NEXT STEP IN ITS GLOBAL EXPANSION

GOTHENBURG, Sweden, Feb. 10, 2026 /PRNewswire/ — Zinzino is pleased to announce that it will launch its operations in Peru…
Read More »
Business Wire10 February 2026

Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026

DALLAS–(BUSINESS WIRE)–Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biopharmaceutical company leveraging artificial intelligence to accelerate oncology drug discovery and development,…
Read More »
Business Wire10 February 2026

Western Missouri Medical Center Chooses MEDITECH Expanse to Advance Care Delivery Across its Hospital and Clinics

Hospital reestablishes MEDITECH partnership with cloud-based Expanse platform, expanding digital capabilities across all care areas CANTON, Mass.–(BUSINESS WIRE)–Western Missouri Medical…
Read More »
Business Wire10 February 2026

Matter Communications Announces Leadership Promotions and Strategic Growth in Boston

BOSTON–(BUSINESS WIRE)–#Marketing—Matter Communications — an agency delivering award-winning PR supported by marketing and creative solutions – today announced the promotion…
Read More »
Business Wire10 February 2026

Prudential Financial Elects Maryann Mannen to Board of Directors

NEWARK, N.J.–(BUSINESS WIRE)–Prudential Financial Inc. (NYSE: PRU) announced today that Maryann Mannen has been elected to the Board of Directors…
Read More »
Business Wire10 February 2026

RXO Launches $400 Million Senior Notes Offering

CHARLOTTE, N.C.–(BUSINESS WIRE)–$RXO #nyse—RXO, Inc. (NYSE: RXO) (the “Company”) today announced it is proposing to issue $400 million aggregate principal…
Read More »
Cision PR Newswire10 February 2026

Iterion Therapeutics Announces First Patient Dosed in Clinical Study of Tegavivint, a First-in-Class Wnt/β-Catenin Inhibitor, in Relapsed/Refractory Osteosarcoma

Tegavivint Is the First Wnt/β-Catenin Inhibitor to Demonstrate Tolerability and Monotherapy Clinical Activity in Complex Solid Tumors Osteosarcoma Program Builds…
Read More »
Cision PR Newswire10 February 2026

On Site: “2026 China Forum on Source Innovation in New Drug Discovery” Concludes Successfully

SHANGHAI, Feb. 10, 2026 /PRNewswire/ — As China’s new drug R&D enters the “deep waters” of homogeneous competition, the path…
Read More »
Cision PR Newswire10 February 2026

Volition Announces the Appointment of New Distributor for Nu.Q® Discover

HENDERSON, Nev., Feb. 10, 2026 /PRNewswire/ — VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), a multi-national epigenetics company, announces the appointment of…
Read More »

Previous page Next page